New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Boosting immunotherapy in non-responsive cancer cells

Boosting immunotherapy in non-responsive cancer cells

by Surabhi Chandra,Indian Institute of ScienceAvik Chattopadhyay working in the lab. Credit: Nikita RamtekeCancer immunotherapy primes a patient's immune system to better find and destroy ca
Oncology January 26,2024
Boosting immunotherapy in non-responsive cancer cells

Boosting immunotherapy in non-responsive cancer cells

by Surabhi Chandra,Indian Institute of ScienceAvik Chattopadhyay working in the lab. Credit: Nikita RamtekeCancer immunotherapy primes a patient's immune system to better find and destroy ca
Oncology January 26,2024
Clinical trial highlights possible treatment for anemia in myelodysplastic neoplasms

Clinical trial highlights possible treatment for anemia in myelodysplastic neoplasms

by Anne Grimm,Leipzig UniversityCredit: Pixabay/CC0 Public DomainIn patients affected by myelodysplastic neoplasms, the body does not produce enough functional blood cells. Patients suffer from
Breakthroughs January 26,2024
Clinical trial highlights possible treatment for anemia in myelodysplastic neoplasms

Clinical trial highlights possible treatment for anemia in myelodysplastic neoplasms

by Anne Grimm,Leipzig UniversityCredit: Pixabay/CC0 Public DomainIn patients affected by myelodysplastic neoplasms, the body does not produce enough functional blood cells. Patients suffer from
Breakthroughs January 26,2024
How an immune response is driven by one letter difference in DNA

How an immune response is driven by one letter difference in DNA

byRadboud UniversityA biphasic circuit regulates IL-1β and IL-37 expression to coordinate pro- and anti-inflammatory processes from within a single TAD. The two functionally opposed states of th
Immunology & Rheumatology January 26,2024
How an immune response is driven by one letter difference in DNA

How an immune response is driven by one letter difference in DNA

byRadboud UniversityA biphasic circuit regulates IL-1β and IL-37 expression to coordinate pro- and anti-inflammatory processes from within a single TAD. The two functionally opposed states of th
Immunology & Rheumatology January 26,2024
Mettl3-dependent m6A modification is essential for effector differentiation and memory formation of CD8+ T cells

Mettl3-dependent m6A modification is essential for effector differentiation and memory formation of CD8+ T cells

byScience China PressDuring viral infection, total m6A levels in Naïve stage, effector stage, and memory stage exhibit dynamic alteration (high-low-high). The presence of Mettl3 promotes CD8 T c
Immunology & Rheumatology January 26,2024
Mettl3-dependent m6A modification is essential for effector differentiation and memory formation of CD8+ T cells

Mettl3-dependent m6A modification is essential for effector differentiation and memory formation of CD8+ T cells

byScience China PressDuring viral infection, total m6A levels in Naïve stage, effector stage, and memory stage exhibit dynamic alteration (high-low-high). The presence of Mettl3 promotes CD8 T c
Immunology & Rheumatology January 26,2024
Five-day antibiotic course noninferior for pediatric febrile UTI

Five-day antibiotic course noninferior for pediatric febrile UTI

by Elana GotkineFor young children with febrile urinary tract infection (fUTI), a five-day amoxicillin-clavulanate course is noninferior to a 10-day course for recurrence of UTI within 30 days after c
Breakthroughs January 26,2024
Five-day antibiotic course noninferior for pediatric febrile UTI

Five-day antibiotic course noninferior for pediatric febrile UTI

by Elana GotkineFor young children with febrile urinary tract infection (fUTI), a five-day amoxicillin-clavulanate course is noninferior to a 10-day course for recurrence of UTI within 30 days after c
Breakthroughs January 26,2024
Using next-gen CRISPR tool, scientists create unprecedented molecular map of human immune response

Using next-gen CRISPR tool, scientists create unprecedented molecular map of human immune response

byGladstone InstitutesCarl Ward, PhD, a postdoctoral researcher in the Marson Lab at Gladstone Institutes, was co-first author of the landmark study in Nature, along with fellow co-first author
Breakthroughs January 26,2024
Using next-gen CRISPR tool, scientists create unprecedented molecular map of human immune response

Using next-gen CRISPR tool, scientists create unprecedented molecular map of human immune response

byGladstone InstitutesCarl Ward, PhD, a postdoctoral researcher in the Marson Lab at Gladstone Institutes, was co-first author of the landmark study in Nature, along with fellow co-first author
Breakthroughs January 26,2024
New antibiotic zosurabalpin shows promise against drug-resistant bacteria: An expert explains

New antibiotic zosurabalpin shows promise against drug-resistant bacteria: An expert explains

by Jonathan Cox,The ConversationCredit: Pixabay/CC0 Public DomainResearchers haveidentifiedan entirely new class of antibiotic that can kill bacteria that are resistant to most curre
Breakthroughs January 26,2024
New antibiotic zosurabalpin shows promise against drug-resistant bacteria: An expert explains

New antibiotic zosurabalpin shows promise against drug-resistant bacteria: An expert explains

by Jonathan Cox,The ConversationCredit: Pixabay/CC0 Public DomainResearchers haveidentifiedan entirely new class of antibiotic that can kill bacteria that are resistant to most curre
Breakthroughs January 26,2024
Alarm over lax oversight of weight loss drug adverts that could harm patients

Alarm over lax oversight of weight loss drug adverts that could harm patients

byBritish Medical JournalCredit: Unsplash/CC0 Public DomainUK organizations responsible for protecting the public from prescription-only drug adverts are putting patients at risk from the harms
Breakthroughs January 26,2024
Alarm over lax oversight of weight loss drug adverts that could harm patients

Alarm over lax oversight of weight loss drug adverts that could harm patients

byBritish Medical JournalCredit: Unsplash/CC0 Public DomainUK organizations responsible for protecting the public from prescription-only drug adverts are putting patients at risk from the harms
Breakthroughs January 26,2024
BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

by Impact Journals LLCPatient examples of inverse correlation of BCMA and FLC changes during course of therapy. Credit: 2023 Springer et al.A new research paper was published inOncotarget, entit
Oncology January 26,2024
BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

by Impact Journals LLCPatient examples of inverse correlation of BCMA and FLC changes during course of therapy. Credit: 2023 Springer et al.A new research paper was published inOncotarget, entit
Oncology January 26,2024
Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

by Liu Jia,Chinese Academy of SciencesA model depicting how the SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Credit: Prof. Wang Yuexi
Oncology January 26,2024
Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

by Liu Jia,Chinese Academy of SciencesA model depicting how the SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Credit: Prof. Wang Yuexi
Oncology January 26,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com